Workflow
Chemicals (TiO2)
icon
Search documents
VALHI REPORTS FIRST QUARTER 2025 RESULTS
Globenewswireยท 2025-05-08 20:15
Core Insights - Valhi, Inc. reported a significant increase in net income attributable to stockholders, reaching $16.9 million or $0.59 per share in Q1 2025, compared to $7.8 million or $0.27 per share in Q1 2024, primarily driven by improved operating results in the Chemicals Segment [1][12]. Chemicals Segment - The Chemicals Segment's net sales were $489.8 million in Q1 2025, an increase of $11 million or 2% from $478.8 million in Q1 2024, attributed to higher sales volumes in North America and Europe, offset by lower export sales and a decline in average TiO2 selling prices [2][12]. - Operating income for the Chemicals Segment rose to $41.2 million in Q1 2025 from $22.8 million in Q1 2024, driven by increased sales and production volumes, higher average TiO2 prices, and reduced production costs [3][12]. - TiO2 production volumes increased by 18% in Q1 2025 compared to Q1 2024, with production facilities operating at average capacities of 93% in 2025 versus 87% in 2024 [3]. Component Products Segment - The Component Products Segment reported net sales of $40.3 million in Q1 2025, up from $38.0 million in Q1 2024, due to increased sales of marine components and security products [4][12]. - Operating income for this segment increased to $5.9 million in Q1 2025 from $3.7 million in Q1 2024, primarily due to higher sales and improved gross margins [4]. Real Estate Management and Development Segment - The Real Estate Management and Development Segment's net sales decreased to $8.5 million in Q1 2025 from $13.8 million in Q1 2024, attributed to a slowdown in development activities and delays in obtaining necessary permits [5][12]. Corporate Expenses - Corporate expenses remained comparable to the same period in 2024, with interest income and other decreasing by $1.4 million due to lower average interest rates and reduced cash balances [6][7]. - Interest expense increased by $1.9 million in Q1 2025 compared to Q1 2024, primarily due to higher debt levels from transactions in the Chemicals Segment [7].